Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
1999
6.8K+
LTM Revenue $2.3B
LTM EBITDA $355M
$2.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Edgewell has a last 12-month revenue of $2.3B and a last 12-month EBITDA of $355M.
In the most recent fiscal year, Edgewell achieved revenue of $2.3B and an EBITDA of $285M.
Edgewell expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Edgewell valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $2.3B | $2.3B | XXX | XXX | XXX |
Gross Profit | $879M | $941M | XXX | XXX | XXX |
Gross Margin | 39% | 42% | XXX | XXX | XXX |
EBITDA | $318M | $285M | XXX | XXX | XXX |
EBITDA Margin | 14% | 13% | XXX | XXX | XXX |
Net Profit | $98.6M | $115M | XXX | XXX | XXX |
Net Margin | 4% | 5% | XXX | XXX | XXX |
Net Debt | $1.2B | $1.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Edgewell's stock price is $30.
Edgewell has current market cap of $1.4B, and EV of $2.7B.
See Edgewell trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.7B | $1.4B | XXX | XXX | XXX | XXX | $3.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Edgewell has market cap of $1.4B and EV of $2.7B.
Edgewell's trades at 1.2x LTM EV/Revenue multiple, and 7.7x LTM EBITDA.
Analysts estimate Edgewell's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Edgewell and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $2.7B | XXX | XXX | XXX |
EV/Revenue | 1.2x | XXX | XXX | XXX |
EV/EBITDA | 9.0x | XXX | XXX | XXX |
P/E | 12.9x | XXX | XXX | XXX |
P/E/Growth | 0.6x | XXX | XXX | XXX |
EV/FCF | 15.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEdgewell's NTM/LTM revenue growth is 1%
Edgewell's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Edgewell's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Edgewell's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Edgewell and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 0% | XXX | XXX | XXX | XXX |
EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
EBITDA Growth | -10% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 14% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 19% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Edgewell acquired XXX companies to date.
Last acquisition by Edgewell was XXXXXXXX, XXXXX XXXXX XXXXXX . Edgewell acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Edgewell founded? | Edgewell was founded in 1999. |
Where is Edgewell headquartered? | Edgewell is headquartered in United States of America. |
How many employees does Edgewell have? | As of today, Edgewell has 6.8K+ employees. |
Who is the CEO of Edgewell? | Edgewell's CEO is Mr. Rod R. Little. |
Is Edgewell publicy listed? | Yes, Edgewell is a public company listed on NYS. |
What is the stock symbol of Edgewell? | Edgewell trades under EPC ticker. |
When did Edgewell go public? | Edgewell went public in 2000. |
Who are competitors of Edgewell? | Similar companies to Edgewell include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Edgewell? | Edgewell's current market cap is $1.4B |
What is the current revenue of Edgewell? | Edgewell's last 12-month revenue is $2.3B. |
What is the current EBITDA of Edgewell? | Edgewell's last 12-month EBITDA is $355M. |
What is the current EV/Revenue multiple of Edgewell? | Current revenue multiple of Edgewell is 1.2x. |
What is the current EV/EBITDA multiple of Edgewell? | Current EBITDA multiple of Edgewell is 7.7x. |
What is the current revenue growth of Edgewell? | Edgewell revenue growth between 2023 and 2024 was 0%. |
Is Edgewell profitable? | Yes, Edgewell is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.